From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA OKs short-acting follow-on insulin for diabetes

from Modern Medicine Network

FDA approved the first short-acting insulin approved as a “follow-on” product. Insulin lispro injection is indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with Type 1 diabetes mellitus and adults with Type 2 diabetes mellitus. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063